<h1>Public issue proposal: company to file draft red herring prospectus and restrict foreign securities offerings pending registration.</h1> Veeda Clinical Research Limited proposes a public issue and intends to file a draft red herring prospectus with the securities regulator subject to approvals and market conditions; the company states securities may not be offered or sold in certain foreign jurisdictions absent registration or an exemption, and any foreign offering will be made via a prospectus containing detailed company and financial information.